The North America Oligonucleotide Synthesis market is expected to reach US$ $ 1,541.03 Mn in 2027 from US$ 609.90 Mn in 2018. The market is estimated to grow with a CAGR of 11.2% from 2019-2027.
Market Growth Driven by Key Factors in the Oligonucleotide Synthesis Industry
The North America Oligonucleotide Synthesis market is experiencing significant growth, fueled by rising investments in pharmaceutical and biotechnology companies, government funding, and the increasing presence of market players focused on expanding their capabilities in this sector. These factors are expected to drive market expansion across the region during the forecast period.
Applications of Oligonucleotides in Research and Therapeutics
Oligonucleotides serve as sequence-specific binding agents in various biological applications, enabling the identification of target DNA sequences. These short, synthetic single-stranded DNA fragments have diverse uses in disease diagnosis, biotechnology research, therapeutics, forensics, and drug discovery.
One key application is in genetic disease diagnosis, where oligonucleotide probes detect single base pair mutations within the human genome. For example, sickle cell anemia—caused by a transversion (A→T) in the β-globin gene—can be diagnosed using labeled oligonucleotides. Under stringent hybridization conditions, these probes can determine whether one or both alleles carry the mutant gene.
Beyond diagnostics, researchers are leveraging oligonucleotides to develop more efficient and sustainable chemical synthesis methods. By assembling oligonucleotides into longer DNA fragments that encode synthetic genes, scientists can engineer bacteria or yeast to produce specific enzymes, streamlining protein synthesis.
Therapeutic Potential and Clinical Advancements
Oligonucleotides also play a crucial role in therapeutic development, allowing scientists to target, silence, or modulate malfunctioning genes. Companies like Ionis Pharmaceuticals specialize in antisense oligonucleotide (ASO) therapeutics, demonstrating the growing potential of oligonucleotide-based treatments.
Recent clinical trials in Canada highlight this progress. For instance, in January 2019, a Phase 3 trial was initiated across the U.S. and Canada to evaluate RG6042 (IONIS-HTTRx), an investigational ASO therapy for Huntington’s disease. Developed by Ionis Pharmaceuticals and later acquired by Roche, this treatment targets mutant huntingtin protein (mHTT), the primary cause of Huntington’s disease. The trial, conducted across six sites in five Canadian provinces, underscores the expanding role of oligonucleotides in neurodegenerative disease treatment.
U.S. Leading Market Growth in North America
The United States is expected to dominate the North America Oligonucleotide Synthesis market due to increasing investments in gene synthesis technologies and rising funding for biotech firms, academic institutions, and research centers. The growing emphasis on precision medicine and oligonucleotide-based therapeutics further strengthens the country’s position as a key contributor to regional market growth.
Given these advancements and the expanding applications of oligonucleotides, the market is poised for substantial growth in the coming years.
North America Oligonucleotide Synthesis market Segmentation
North America Oligonucleotide Synthesis Market By Product
- Synthesized Oligonucleotides
- Primers
- Probes
- Large-Scale Synthesis
- Others
- Reagents
- Equipment
North America Oligonucleotide Synthesis market By Application
- Research
- Diagnostics
- Therapeutics
North America Oligonucleotide Synthesis market By End User
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Other End Users
North America Oligonucleotide Synthesis market By Geography
- North America
- US
- Canada
- Mexico
North America Oligonucleotide Synthesis market Company Profiles
- Thermo Fisher Scientific Inc.
- GenScript
- Molecular Assemblies
- Twist Biosciences
- Evonetix
- DNA Script
- Nuclera Nucleics
- Camena Bioscience
- Synthomics
- Ansa Biotechnologies
North America Oligonucleotide Synthesis market Strategic Insights
Strategic insights for the North America Oligonucleotide Synthesis market provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the North America Oligonucleotide Synthesis market.
Other Reports:
Europe Hair Color Market: https://penzu.com/p/6f37455f846d0470
Europe Lubricant Additives Market: https://business-news-insights.blogspot.com/2025/05/europe-lubricant-additives-market-share.html
Europe Electric Bus Market: https://github.com/SuryakantGadekar/Business-Market-Insights/issues/49
Europe Non-Alcoholic Steatopatitis Market: https://businessnews46.wordpress.com/2025/05/14/europe-electric-bus-market-a-higher-value-by-2028-with-a-whooping-cagr/
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
